Research and Markets: DUSA Pharmaceuticals Inc - Product Pipeline Report Available Now
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c75009) has announced the addition of "DUSA Pharmaceuticals Inc - Product Pipeline Report" to their offering.
The DUSA Pharmaceuticals Inc Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail), product revenue, trademarks, corporate partners and management profiles.
Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.
Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The DUSA Pharmaceuticals Inc Product Pipeline Report therefore delivers the latest and the most comprehensive intelligence available on DUSA Pharmaceuticals Inc's current pipeline portfolio.
Topics Covered:
Product Pipeline Reports
Business Summary
Contact Information
Selected Financial Data
Company Details
Product Glance (Table/Graph)
Disease Hub Classification (Table/Graph)
Product Pipeline
Product Catalog
Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc.
Patent Details (if any)
Recent Financings
Trademarks
Deals & Alliances
Management Profile
Recent Updates
For more information, visit http://www.researchandmarkets.com/reports/c75009.
Contacts
Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com
The DUSA Pharmaceuticals Inc Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail), product revenue, trademarks, corporate partners and management profiles.
Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.
Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The DUSA Pharmaceuticals Inc Product Pipeline Report therefore delivers the latest and the most comprehensive intelligence available on DUSA Pharmaceuticals Inc's current pipeline portfolio.
Topics Covered:
Product Pipeline Reports
Business Summary
Contact Information
Selected Financial Data
Company Details
Product Glance (Table/Graph)
Disease Hub Classification (Table/Graph)
Product Pipeline
Product Catalog
Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc.
Patent Details (if any)
Recent Financings
Trademarks
Deals & Alliances
Management Profile
Recent Updates
For more information, visit http://www.researchandmarkets.com/reports/c75009.
Contacts
Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.